In Brief: 3M/PyMah
This article was originally published in The Gray Sheet
3M/PyMah: Sign agreement under which 3M will acquire Flemington, New Jersey-based PyMah, a manufacturer and marketer of sterilization monitoring, vital signs and industrial monitoring equipment, for undisclosed terms. After the deal's closing, expected within the next 30 days, 3M will assume operation of PyMah's Flemington facility, "offering 3M employment to a majority of workers there." PyMah will retain responsibility of its facilities located in Hollywood, California and Athy, Ireland...
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.